Deals

cancer target detection radiopharma radio
Biotech

Lyell signs deal for phase 1-stage colorectal cancer CAR-T

Lyell is handing over $40 million in cash and almost 2 million of its shares to secure a phase 1-stage CAR-T cell therapy for colorectal cancer.
James Waldron Nov 10, 2025 9:45am
Robot hands with a pieces of the puzzle

Lilly continues AI push, inking $100M-plus deal with Insilico

Nov 10, 2025 9:00am
IPO initial public offering Wall Street

DNA test maker BillionToOne raises $314M in IPO, shares dip

Nov 10, 2025 8:45am
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Lilly bags eye-catching gene therapy in $475M deal

Nov 10, 2025 7:00am
Pfizer

Pfizer beats out Novo with $10B agreement to buy Metsera

Nov 8, 2025 8:11am
Brain and money connected by a thread on a white background

Axsome adds AZ asset through Avenue subsidiary acquisition

Nov 6, 2025 10:50am